CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 471 filers reported holding CRISPR THERAPEUTICS AG in Q3 2021. The put-call ratio across all filers is 1.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,070,523 | -19.1% | 23,585 | 0.0% | 0.29% | -16.3% |
| Q2 2023 | $1,324,062 | +21.8% | 23,585 | -1.8% | 0.35% | +17.5% |
| Q1 2023 | $1,086,651 | +9.2% | 24,025 | -1.8% | 0.30% | +4.2% |
| Q4 2022 | $994,706 | -39.5% | 24,470 | -2.7% | 0.28% | -45.5% |
| Q3 2022 | $1,644,000 | +4.1% | 25,159 | -3.2% | 0.52% | +15.2% |
| Q2 2022 | $1,579,000 | -4.3% | 25,979 | -1.1% | 0.45% | +10.7% |
| Q1 2022 | $1,650,000 | -18.6% | 26,280 | -1.7% | 0.41% | -13.3% |
| Q4 2021 | $2,026,000 | -34.1% | 26,740 | -2.6% | 0.47% | -39.9% |
| Q3 2021 | $3,074,000 | -29.8% | 27,460 | +1.5% | 0.79% | -29.7% |
| Q2 2021 | $4,379,000 | +32.7% | 27,050 | -0.1% | 1.12% | +20.6% |
| Q1 2021 | $3,300,000 | -25.0% | 27,080 | -5.8% | 0.93% | -29.8% |
| Q4 2020 | $4,402,000 | +67.4% | 28,750 | -8.5% | 1.32% | +56.9% |
| Q3 2020 | $2,629,000 | -8.2% | 31,430 | -19.3% | 0.84% | -14.6% |
| Q2 2020 | $2,864,000 | +65.1% | 38,965 | -4.8% | 0.99% | +44.6% |
| Q1 2020 | $1,735,000 | -34.1% | 40,915 | -5.4% | 0.68% | -12.0% |
| Q4 2019 | $2,634,000 | +47.0% | 43,240 | -1.1% | 0.78% | +35.7% |
| Q3 2019 | $1,792,000 | -13.6% | 43,725 | -0.8% | 0.57% | -13.9% |
| Q2 2019 | $2,075,000 | +31.6% | 44,060 | -0.2% | 0.66% | +28.7% |
| Q1 2019 | $1,577,000 | +22.9% | 44,155 | -1.7% | 0.52% | +9.6% |
| Q4 2018 | $1,283,000 | -37.7% | 44,915 | -3.2% | 0.47% | -32.5% |
| Q3 2018 | $2,058,000 | -38.6% | 46,405 | -18.7% | 0.70% | -54.8% |
| Q2 2018 | $3,354,000 | +28.6% | 57,080 | +0.0% | 1.54% | +40.0% |
| Q1 2018 | $2,609,000 | +130.3% | 57,075 | +18.3% | 1.10% | +129.4% |
| Q4 2017 | $1,133,000 | – | 48,257 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |